.After introducing a stage 3 launch based on good midstage outcomes, iTeos and GSK are eventually di...
.The FDA needs to be actually extra open and also joint to release a surge in approvals of uncommon ...
.It's an abnormally busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara Th...
.Atea Pharmaceuticals' antiviral has actually failed yet another COVID-19 test, however the biotech ...
.Neurocrine Biosciences' mental illness plan pivot has actually failed. The biotech was unable to re...
.Sanofi has brought in an overdue entry to the radioligand gathering, spending one hundred thousand ...
.After F2G's initial attempt to get a new training class of antifungal to market was derailed due to...
.Moderna has actually promised to reduce R&D costs through $1.1 billion by 2027. The decision to ...
.Simply four months after Sanofi wager $80 thousand in beforehand money on Fulcrum Therapeutics' los...
.Cancer cells firm Oncternal Therapies is actually folding all its own professional trials and also ...